Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank

Area of Science:

• Rheumatology
• Nephrology
• Cardiology
• Metabolic Syndrome

Background:

• Gout is a common inflammatory arthritis associated with metabolic and cardiovascular comorbidities.
• Serum urate (SU) is a key factor in gout pathogenesis, but its relationship with comorbidities is complex.
• Understanding these associations is crucial for managing gout and its related health issues.

Purpose of the Study:

• To investigate the association between various comorbidities and serum urate (SU) levels.
• To examine the relationship between gout and comorbidities.
• To determine if the association between gout and comorbidities is independent of SU levels.

Main Methods:

• A case-control study utilizing UK Biobank data from 458,781 participants.
• Two analyses: 1) comorbidities and SU (excluding gout patients), 2) gout and comorbidities (gout patients as index condition).
• Logistic regression used to calculate adjusted odds ratios (aORs) for associations, controlling for covariates including SU and comorbidities.

Main Results:

• Comorbidities including hypertension, ischemic heart disease (IHD), congestive cardiac failure (CCF), hyperlipidemia, and chronic kidney disease (CKD) were associated with increased SU.
• Gout was independently associated with hypertension, IHD, CCF, hyperlipidemia, and diabetes, with aORs ranging from 1.21-4.15, even after adjusting for SU.
• Each 1 mg/dl increase in SU was associated with a 1.10-3.14 aOR for these comorbidities.

Conclusions:

• Comorbidities are associated with elevated serum urate levels.
• The link between gout and cardiometabolic comorbidities is independent of serum urate levels.
• This suggests SU-independent mechanisms, potentially involving inflammation, genetics, or diet, drive the gout-comorbidity association.